IL-13 exerts pleiotropic effects on immune cells:
B Cells: Induces IgE class switching and upregulates MHC class II/CD23 expression .
Macrophages: Suppresses proinflammatory cytokines (e.g., TNF-α, IL-6) .
Fibroblasts/Endothelial Cells: Modulates IL-6 and IL-1β production .
Assay | Activity | Source |
---|---|---|
TF-1 Cell Proliferation | ED₅₀ < 1.0 ng/mL (specific activity >1×10⁶ U/mg) | Prospec Bio |
A-549 Cell Bioassay | Validated for therapeutic antagonist testing | R&D Systems |
ELISpot: Detection of IL-13-secreting cells using cross-reactive human/macaque antibody pairs (Mabtech) .
ELISA: Quantification in serum/plasma (sensitivity: 0.045 ng/mL; Thermo Fisher EP12RB kit) .
Asthma Pathogenesis: Mediates airway hyperresponsiveness independent of IgE .
Vaccine Studies: Correlates with eosinophil levels and Th2 immunity in RSV challenge models .
Dermatopathology: Linked to Th2 skewing in alopecia and atopic dermatitis .
Th2 Immunity Regulation: IL-13+ T cells coordinate with GATA3+ regulatory T cells to maintain caecal homeostasis in macaques .
Vaccine Efficacy: Elevated IL-13 correlates with reduced protective efficacy in RSV vaccine trials, highlighting its dual role in immunity .
Therapeutic Targeting: The R110Q IL-13 variant shows enhanced activity in eosinophils, implicating IL-13Rα2 as a therapeutic checkpoint .
Interleukin-13 (IL-13) is a cytokine expressed by the IL13 gene and secreted by multiple cell types, with type 2 helper T-cells (Th2) being the predominant source. In rhesus macaques, mature IL-13 shares 95% amino acid sequence identity with human IL-13, making it an excellent translational model for human immunological research . By comparison, rhesus IL-13 shares only 59% and 60% sequence identity with mouse and rat IL-13, respectively . This high homology between human and rhesus macaque IL-13 explains why rhesus macaques are preferred over rodent models for studying IL-13-mediated immune responses relevant to human diseases.
Rhesus macaque IL-13 is a monomeric protein with a molecular weight of approximately 12.6 kDa, consisting of 114 amino acids . The high solution form features two internal disulfide bonds that contribute to its bundled four α-helix configuration, which is critical for its receptor binding and biological activity . For research applications, recombinant rhesus IL-13 is typically available as a sterile filtered white lyophilized powder that should be stored desiccated at -20°C to maintain stability .
IL-13 in rhesus macaques performs several crucial immunoregulatory functions:
Anti-inflammatory effects: IL-13 exerts potent anti-inflammatory actions on monocytes and macrophages .
Cytokine inhibition: It suppresses the expression of pro-inflammatory cytokines including IL-1β, TNF-α, IL-6, and IL-8 .
B-cell modulation: IL-13 enhances B-cell proliferation and induces isotype switching, resulting in increased production of IgE antibodies .
Th2 development: Studies with targeted deletion models suggest IL-13 plays an important role in Th2 cell development .
Parasite response: IL-13 appears to be significant in the expulsion of gastrointestinal parasites, as demonstrated in comparable knockout studies .
The expression pattern of IL-13 in rhesus macaques during infection appears to be disease-specific. In pertussis infection studies, unlike pro-inflammatory cytokines (IL-6, IL-1β, TNF-α) which show significant upregulation, IL-13 levels do not exhibit marked changes . This differential expression highlights the specialized role IL-13 may play in different infectious contexts, suggesting it might be more involved in allergic and parasitic responses rather than bacterial infections like pertussis .
When designing experiments to study IL-13 function in rhesus macaques, researchers should consider:
Age selection: Different age cohorts may show varying immune responses. Studies indicate age can significantly affect immune parameters in rhesus macaques .
Sex consideration: Sex differences have been observed in certain immunological responses in rhesus macaques and should be accounted for in experimental design .
Origin consideration: Chinese-origin and Indian-origin rhesus macaques display differences in disease pathogenesis and immunological responses . Researchers should select consistent populations or account for this variable.
Control design: Implement appropriate control conditions, as demonstrated in behavioral studies where test and control trials showed significantly different responses .
Sampling schedule: For cytokine analysis, implement time-course sampling to capture the dynamic changes in IL-13 expression following immune challenge .
For optimal IL-13 measurement in rhesus macaque samples:
Sample collection: Collect serum samples for systemic IL-13 levels. For mucosal responses, consider nasopharyngeal washes (NPW) or bronchoalveolar lavage .
Assay selection: Use rhesus-specific or cross-reactive human IL-13 immunoassays validated for macaque samples.
Panel design: Measure IL-13 alongside related cytokines (IL-4, IL-10, IFN-γ) to properly contextualize Th1/Th2 balance .
Timing: Based on infection studies, consider multiple sampling timepoints (days 0, 5, 10, 15, 25, and 35 post-challenge) to properly capture the dynamics of cytokine responses .
While specific IL-13 variation between populations has not been fully characterized, broader immunological differences between Chinese-origin and Indian-origin rhesus macaques have been documented. These populations show differences in:
Disease pathogenesis: Differential susceptibility and progression in certain disease models .
Immune parameters: Variations in blood chemistry and major histocompatibility complex genetics .
Cytokine responses: Potential differences in cytokine expression profiles, though specific IL-13 comparative data is limited .
Research indicates that rhesus macaques possess exceptionally high levels of single nucleotide polymorphisms (SNPs) - approximately twice as high as those observed in most human populations . This genetic diversity may impact cytokine expression and function, including IL-13, and should be considered when designing experiments and interpreting results from different rhesus macaque populations.
Despite the high homology between rhesus and human IL-13, several translational challenges exist:
Genetic diversity: The high genetic diversity in rhesus macaques can create issues for broad applicability of study results .
Population differences: Variations between Chinese-origin and Indian-origin rhesus macaques in disease susceptibility and immune responses complicate translation .
Developmental differences: Age-related effects on immune responses may differ between macaques and humans .
Sex-specific effects: Sex differences in immune responses may not directly parallel those in humans .
In rhesus macaque models of infection and inflammation, IL-13 functions within a complex cytokine network. Studies examining pertussis infection have analyzed IL-13 alongside multiple other cytokines including IL-1β, IL-4, IL-6, IL-8, IL-10, IL-12/23p40, IL-17A, IFN-γ, and TNF-α . While IL-13 itself didn't show significant changes during pertussis infection, the upregulation of IL-6, IL-1β, TNF-α, IL-12/23p40, and IL-10 suggests a complex interplay between different immune pathways . This indicates that IL-13 should be studied not in isolation but as part of the broader immune signaling network specific to different disease contexts.
Current technical limitations include:
Reagent availability: Limited availability of rhesus-specific research reagents compared to human or mouse models.
Standardization challenges: Variability in recombinant IL-13 preparations and detection methods across studies.
Genetic background effects: The high genetic diversity of rhesus macaques (with SNP levels twice that of humans) complicates interpretation of results and requires larger sample sizes .
Population-specific reference ranges: Incomplete characterization of normal IL-13 expression levels across different rhesus macaque populations.
Promising future research directions include:
Population-specific cytokine profiling: Comprehensive characterization of IL-13 expression and function across different rhesus macaque populations.
Systems biology approaches: Integration of IL-13 data with genomic, transcriptomic, and proteomic datasets to understand broader immune networks.
Therapeutic targeting studies: Evaluation of IL-13-targeted therapies for allergic and inflammatory conditions using rhesus macaque models.
Comparative immunology: Detailed comparative analyses of IL-13 signaling pathways between human and rhesus macaque systems.
To address population variability:
Genetic screening: Implement genetic screening protocols to characterize IL-13 pathway polymorphisms in study subjects.
Population-specific controls: Establish population-specific reference ranges for normal IL-13 expression.
Mixed-model statistical approaches: Use statistical methods that account for population differences when analyzing data from diverse rhesus macaque sources.
Cross-population validation: Validate findings across multiple populations before extrapolating to human applications.
Interleukin-13 (IL-13) is a cytokine that plays a crucial role in the immune system, particularly in the regulation of inflammatory responses. It is involved in various biological processes, including the modulation of immune cell activity, the promotion of allergic responses, and the regulation of tissue remodeling. Recombinant IL-13 from rhesus macaques (Macaca mulatta) is used in research to study these processes in a model that closely resembles human physiology.
Rhesus macaques are widely used in biomedical research due to their genetic, physiological, and immunological similarities to humans . These primates have been instrumental in the development of vaccines, the study of infectious diseases, and the understanding of immune responses. The use of recombinant proteins from rhesus macaques allows researchers to investigate the effects of these proteins in a controlled and reproducible manner.
IL-13 is produced primarily by T-helper type 2 (Th2) cells and is involved in the regulation of immune responses. It shares many functions with IL-4, including the promotion of B-cell proliferation and differentiation, the induction of class switch recombination to IgE, and the regulation of macrophage activity. IL-13 also plays a role in the pathogenesis of allergic diseases, such as asthma and atopic dermatitis, by promoting the production of mucus and the recruitment of eosinophils to sites of inflammation .
Recombinant IL-13 is produced using genetic engineering techniques. The gene encoding IL-13 is cloned into an expression vector, which is then introduced into a host cell line, such as Escherichia coli or Chinese hamster ovary (CHO) cells. The host cells express the IL-13 protein, which is subsequently purified using chromatography techniques. The recombinant IL-13 can then be used in various experimental assays to study its biological effects .
Recombinant IL-13 from rhesus macaques is used in a variety of research applications, including: